A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : 99mTc

Search Conditions:
Search Keyword : 99mTc
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: 99mTc
Appearance Frequency: 214 time(s)
Long forms: 125

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
99mTechnetium
(55 times)
Neoplasms
(8 times)
SPECT (6 times)
CT (3 times)
PET (3 times)
1979 Detection of deep venous thrombosis by scanning of 99mtechnetium-labelled red-cell venous pool.
means of technetium-99m
(11 times)
Pediatrics
(2 times)
SPECT (3 times)
111In (1 time)
82Rb (1 time)
1996 In utero defecation by the normal fetus: a radionuclide study in the rabbit.
99mTc-pertechnetate
(7 times)
Nuclear Medicine
(2 times)
AIA (1 time)
KCS (1 time)
SS (1 time)
1981 Detection and quantification of experimental joint inflammation in mice by measurement of 99mTc-pertechnetate uptake.
meal labelled with technetium-99M
(5 times)
Urology
(1 time)
DTPA (2 times)
AMPs (1 time)
E. coli (1 time)
1984 Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction.
muCi 99mTechnetium pertechnetate
(5 times)
Molecular Biology
(1 time)
GD (1 time)
PC (1 time)
1984 Quantitation of arthritis by 99mTc-uptake measurements in the mouse knee-joint: correlation with histological joint inflammation scores.
technetium-99 m
(4 times)
Cell Biology
(1 time)
p.i (1 time)
RBC (1 time)
1992 Evaluation of thrombus detection in a rabbit model using a technetium-99m-labelled anti-fibrin monoclonal antibody.
99-metastable-technetium
(2 times)
Pharmacy
(1 time)
133Xe (1 time)
81mKr (1 time)
COPD (1 time)
2006 [Research of 99mTcO4- and 99mTcO2- in injectable solutions of 99mTc-HMDP by inverse phase HPTLC].
99mTc to prepare
(2 times)
Biology
(1 time)
LDL (1 time)
PSMA (1 time)
RCP (1 time)
1985 Technetium-99m low density lipoproteins: preparation and biodistribution.
99mTc-labeled tropane derivative
(2 times)
Nuclear Medicine
(2 times)
DAT (1 time)
L-dopa (1 time)
MPTP (1 time)
1997 [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent.
10  mapping and technetium-99m
(2 times)
General Surgery
(1 time)
HMPAO (1 time)
ICG (1 time)
NIR (1 time)
1994 Electroencephalographic mapping and 99mTc HMPAO single-photon emission computed tomography in carbon monoxide poisoning.
11  method for labeling antibodies with technetium-99m
(2 times)
Nuclear Medicine
(2 times)
--- 1990 Reduction-mediated technetium-99m labeling of monoclonal antibodies.
12  method with Technetium-99m
(2 times)
Science
(1 time)
DTPA (1 time)
FA (1 time)
Ig (1 time)
2015 Anti-CD20 Immunoglobulin G Radiolabeling with a 99mTc-Tricarbonyl Core: In Vitro and In Vivo Evaluations.
13  ml technectium-99m
(2 times)
Nuclear Medicine
(1 time)
113mIn (1 time)
CV (1 time)
OSCGM (1 time)
1996 Effects of cisapride on gastric emptying of oil and aqueous meal components, hunger, and fullness.
14  modify the labeling of blood constituents with technetium-99m
(2 times)
Biology
(2 times)
BC (2 times)
AAP (1 time)
ASA (1 time)
2005 Influence of antipyretic drugs on the labeling of blood elements with technetium-99m.
15  99m-labelled sodium pertechnetate
(1 time)
Otolaryngology
(1 time)
CT (1 time)
TFT (1 time)
TGDR (1 time)
1997 Current management of thyroglossal-duct remnant.
16  99m-labelled technetium
(1 time)
Pulmonary Medicine
(1 time)
BAL (1 time)
1994 Imaging of pulmonary disease in scleroderma with J001X scintigraphy.
17  99m-Technetium-labeled
(1 time)
Science
(1 time)
FDG (1 time)
PET (1 time)
2019 In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes.
18  99m-technetium-labeled tin colloid
(1 time)
Neoplasms
(1 time)
SLN (1 time)
2017 The detection of sentinel lymph nodes in laparoscopic surgery can eliminate systemic lymphadenectomy for patients with early stage endometrial cancer.
19  99mTc complexes
(1 time)
Nuclear Medicine
(1 time)
AD (1 time)
2005 Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain.
20  99mTc places
(1 time)
Nuclear Medicine
(1 time)
FUO (1 time)
HMPAO (1 time)
IBD (1 time)
1994 The utility of [99mTc]HMPAO-leukocytes for imaging infection.
21  99mTc to yield the target complexes
(1 time)
Nuclear Medicine
(1 time)
--- 1987 Technetium-99m bis (aminoethanethiol) complexes with amine sidechains--potential brain perfusion imaging agents for SPECT.
22  99mTc unter Verwendung des Radiotracers
(1 time)
Nuclear Medicine
(1 time)
LET (2 times)
CFA (1 time)
2018 Radiotoxicity of alpha particles versus high and low energy electrons in hypoxic cancer cells.
23  99mTc using the tracer
(1 time)
Nuclear Medicine
(1 time)
LET (2 times)
CFA (1 time)
2018 Radiotoxicity of alpha particles versus high and low energy electrons in hypoxic cancer cells.
24  99mTc(Sn)-MDP complex, whereas
(1 time)
Radiology
(1 time)
--- 1984 Electrolytically labeled [99mTc]MDP: chromatographic pattern, stability and biodistribution in rats.
25  99mTc, using either Sn(II) or sodium borohydride to reduce sodium
(1 time)
Chemistry
(1 time)
BAT (1 time)
SPECT (1 time)
1985 Synthesis of new bis(aminoethanethiol) (BAT) derivatives: possible ligands for 99mTc brain imaging agents.
26  99mTc-analogues of (123/131I)mIBG prepared via
(1 time)
Nuclear Medicine
(1 time)
AEG (1 time)
DMI (1 time)
IDA (1 time)
2019 Synthesis and evaluation of 99mTc-analogues of [123/131I]mIBG prepared via [99mTc][Tc(CO)3(H2O)3]+ synthon for targeting norepinephrine transporter.
27  99mTc-analogues of the radio-iodinated derivative following
(1 time)
Nuclear Medicine
(1 time)
AEG (1 time)
DMI (1 time)
IDA (1 time)
2019 Synthesis and evaluation of 99mTc-analogues of [123/131I]mIBG prepared via [99mTc][Tc(CO)3(H2O)3]+ synthon for targeting norepinephrine transporter.
28  99mTc-colloids, unbound
(1 time)
Radiopharmaceuticals
(1 time)
--- 2020 Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow).
29  99mTc-DMSA or
(1 time)
Nuclear Medicine
(1 time)
--- 1995 Tubular reabsorption of technetium-99m-DMSA.
30  99mTc-glucoheptonate or
(1 time)
Biochemistry
(1 time)
--- 1996 Thiolations, 99mTc labelings, and animal in vivo biodistributions of divalent monoclonal antibody fragments.
31  99mTc-HEDP
(1 time)
Nuclear Medicine
(1 time)
--- 1992 MIRD Pamphlet No. 14: a dynamic urinary bladder model for radiation dose calculations.
32  99mTc-labeled alpha-hydroxy acid especially
(1 time)
Nuclear Medicine
(1 time)
CO (1 time)
NO (1 time)
2019 Imaging of the third gasotransmitter hydrogen sulfide using 99mTc-labeled alpha-hydroxy acids.
33  99mTc-labeled colloidal rhenium sulfate ((99mTc)colloid)
(1 time)
Nuclear Medicine
(1 time)
HSA (1 time)
HYNIC (1 time)
NMA (1 time)
2004 99mTc-labeled mannosyl-neoglycoalbumin for sentinel lymph node identification.
34  99mTc-labeled hippuran analog
(1 time)
Nuclear Medicine
(1 time)
ACE (1 time)
1988 Abnormal captopril renogram with a technetium-99m-labeled hippuran analog.
35  99mTc-labeled radiopharmaceuticals
(1 time)
Nuclear Medicine
(1 time)
CUDs (1 time)
ITLC (1 time)
1992 A study of the concept of non-radioactive unit-dosed reagent kits [cold unit doses (CUDs)] as an efficient and cost-saving method for 99mTc radiopharmaceutical preparation.
36  99mTc-labeled sigma receptor imaging agent
(1 time)
Nuclear Medicine
(1 time)
--- 2001 Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent.
37  99mTc-labeling, single species radiopeptides
(1 time)
Chemistry
(1 time)
NTS1-R (1 time)
2006 Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTc.
38  99mTc-labelled analogue
(1 time)
Nuclear Medicine
(1 time)
PET (1 time)
2019 The next era of renal radionuclide imaging: novel PET radiotracers.
39  99mTc-radiopharmaceutical
(1 time)
Nuclear Medicine
(1 time)
--- 2002 Synthesis and evaluation of 99mTc(CO)(3)-DTPA-folate as a folate-receptor-targeted radiopharmaceutical.
40  99mTc-sestamibi imaging was performed followed by a separate-day
(1 time)
Nuclear Medicine
(1 time)
--- 1996 Technetium-99m-pertechnetate uptake by intrathyroidal parathyroid adenoma.
41  99mTc-sulfur colloid prepared with the reduced heating protocol and utilizing
(1 time)
Nuclear Medicine
(1 time)
--- 1996 Technetium-99m-sulfur colloid for lymphoscintigraphy: effects of preparation parameters.
42  99mTc-tricarbonyl-nitrilotriacetic acid
(1 time)
Nuclear Medicine
(1 time)
--- 2021 Head to head comparison of [99mTc]Tc(CO)3(NTA) and [99mTc]Tc-MAG3 in patients with suspected obstruction.
43  99mTcO4
(1 time)
Nuclear Medicine
(1 time)
BBB (1 time)
CBF (1 time)
FDG (1 time)
1994 Radiopharmaceuticals for brain imaging.
44  99mTechnetium-colloids
(1 time)
Hematology
(1 time)
111In (1 time)
MF (1 time)
1985 Diagnostic value of bone marrow imaging with 111indium-transferrin and 99m technetium-colloids in myelofibrosis.
45  computed tomography/computed tomography (SPECT/CT) with technetium-99m
(1 time)
Transplantation
(1 time)
ARD (1 time)
CKD (1 time)
SPECT/CT (1 time)
2020 Renal SPECT/CT with 99mTc-dimercaptosuccinic acid is a non-invasive predictive marker for the development of interstitial fibrosis in a rat model of renal insufficiency.
46  dual-modality imaging agent that can be labeled with both technetium-99m
(1 time)
Diagnostic Imaging
(1 time)
ASGPR (1 time)
Gd (1 time)
pVLND2 (1 time)
2016 A Novel Copolymer-Based Functional SPECT/MR Imaging Agent for Asialoglycoprotein Receptor Targeting.
47  examine the time-course and relationships of technetium-99m
(1 time)
Physiology
(1 time)
DOMS (1 time)
IL-6 (1 time)
MHC (1 time)
2001 Markers of inflammation and myofibrillar proteins following eccentric exercise in humans.
48  mAb labeled with a technetium-99m
(1 time)
Neurology
(1 time)
EGFR (2 times)
mAb (1 time)
2003 Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor.
49  macroaggregates of albumin labeled with technetium-99m
(1 time)
Pulmonary Medicine
(1 time)
--- 1979 Effect of local radioactivity on trachael mucous velocity of sheep.
50  made in using a technetium-99m dopamine transporter imaging agent
(1 time)
Nuclear Medicine
(1 time)
--- 2007 Clinical acceptance of a molecular imaging agent: a long march with [99mTc]TRODAT.
51  magnetic resonance imaging enterography, technetium 99m scintigraphy
(1 time)
Endoscopy, Gastrointestinal
(1 time)
MD (1 time)
2016 Balloon-assisted enteroscopy for suspected Meckel's diverticulum and indefinite diagnostic imaging workup.
52  man using indium 111 chloride, technetium-99m
(1 time)
Nuclear Medicine
(1 time)
--- 1991 Recent advances in bone marrow scanning.
53  management with stress/rest technetium-99m
(1 time)
Cardiology
(1 time)
18FDG (1 time)
CABG (1 time)
PET (1 time)
2001 No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium.
54  mansoni cercaria with technetium-99m
(1 time)
Nuclear Medicine
(1 time)
--- 1992 Conditions for labeling of Schistosoma mansoni cercaria with technetium-99m.
55  manufacturing of technetium-99m
(1 time)
Pharmacology
(1 time)
99Mo (1 time)
2012 Future of low specific activity molybdenum-99/technetium-99m generator.
56  many advantages of technetium-99m
(1 time)
Gastroenterology
(1 time)
111In (1 time)
1994 Investigation of suspected intra-abdominal sepsis: the contribution of nuclear medicine.
57  many desirable characteristics of technetium-99m
(1 time)
Molecular Biology
(1 time)
--- 2003 Assessment of the effect of Punica granatum (pomegranata) on the bioavailability of the radiopharmaceutical sodium pertechnetate (99mTc) in Wistar rats.
58  many radiopharmaceutical products with technetium-99m
(1 time)
Genetics
(1 time)
--- 1998 Mutational potentiality of stannous chloride: an important reducing agent in the Tc-99m-radiopharmaceuticals.
59  marrow imaging performed with technetium 99m
(1 time)
Radiology
(1 time)
WBC (1 time)
2006 Combined labeled leukocyte and technetium 99m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection.
60  may augment the tumor uptake, technetium-99m
(1 time)
Clinical Laboratory Techniques
(1 time)
BRMs (1 time)
IFN (1 time)
p.i (1 time)
1992 Evaluation of biological response modifiers in the enhancement of tumor uptake of technetium-99m labeled macromolecules. A preliminary report.
61  Meanwhile, high-dose carvedilol reduced renal accumulation of Technetium-99m
(1 time)
Toxicology
(1 time)
--- 2020 The effects of carvedilol, metoprolol and propranolol on cisplatin-induced kidney injury.
62  measured using constant infusion of technetium 99m
(1 time)
Vascular Diseases
(1 time)
--- 2005 Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension.
63  measured using Technetium-99m
(1 time)
Nuclear Medicine
(1 time)
CWs (1 time)
RTD (1 time)
2019 Investigation of flow dynamics of wastewater in a pilot-scale constructed wetland using radiotracer technique.
64  measurements of the pharmacokinetics of technetium-99m
(1 time)
Nuclear Medicine
(1 time)
57Co (1 time)
MIRD (1 time)
SEE (1 time)
1989 A practical SPECT technique for quantitation of drug delivery to human tumors and organ absorbed radiation dose.
65  measurements of the system response for the commonly used Technetium-99m
(1 time)
Nuclear Medicine
(1 time)
FOV (1 time)
FWHM (1 time)
OSEM (1 time)
2020 Performance assessment of the ALBIRA II pre-clinical SPECT S102 system for 99mTc imaging.
66  measuring radiochemical purity and estimated lung trapping of colloidal technetium-99m
(1 time)
Pharmacology
(1 time)
--- 1989 Technetium-99m radiochemical assay by rapid filtration: a superior alternative to chromatography.
67  medical radioisotopes technetium Tc 99m
(1 time)
Public Health
(1 time)
201Tl (1 time)
DE (1 time)
2014 Scintigraphic Evaluation of Decontamination Lotion for Removal of Radioactive Contamination From Skin.
68  medicine diagnostic procedures use technetium-99m
(1 time)
Nuclear Medicine
(1 time)
DTPA (1 time)
MDP (1 time)
2006 Cytotoxic and genotoxic effects induced by stannous chloride associated to nuclear medicine kits.
69  medicine to produce radiopharmaceuticals labeled with technetium-99m
(1 time)
Toxicology
(1 time)
DNA (1 time)
GHA (1 time)
1998 Cellular inactivation induced by a radiopharmaceutical kit: role of stannous chloride.
70  membranes of human erythrocytes during labeling with technetium-99m
(1 time)
Nuclear Medicine
(1 time)
--- 1990 Radiolabeling of erythrocytes with technetium-99m: role of band-3 protein in the transport of pertechnetate across the cell membrane.
71  mesenchymal stem cells labeled with Technetium-99m
(1 time)
Radiology
(1 time)
--- 2015 Scintigraphic tracking of mesenchymal stem cells after portal, systemic intravenous and splenic administration in healthy beagle dogs.
72  metabolic tracer, technetium-99m
(1 time)
Cardiology
(1 time)
201Tl (1 time)
FDG (1 time)
PET (1 time)
1993 The noninvasive assessment of myocardial viability.
73  metastable technetium-99
(1 time)
Chemistry, Pharmaceutical
(1 time)
DATs (1 time)
PD (1 time)
2019 Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen, for the Radiolabeling of beta-CIT with Iodine-131: Relevance for Parkinson's Disease.
74  method applied to gated technetium-99m
(1 time)
Radiology
(1 time)
SPECT (1 time)
1998 Computer-assisted myocardial thickening analysis of gated MIBI SPECT images.
75  method for correcting of scattered photons in technetium-99m
(1 time)
Nuclear Medicine
(1 time)
ASW (1 time)
SW (1 time)
1992 Correction of scattered photons in Tc-99m imaging by means of a photopeak dual-energy window acquisition.
76  method for labelling preformed liposomes with technetium-99m
(1 time)
Nuclear Medicine
(1 time)
HM-PAO (1 time)
1992 A simple method for producing a technetium-99m-labeled liposome which is stable in vivo.
77  method of producing technetium-99m
(1 time)
Nuclear Medicine
(1 time)
--- 1987 Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions.
78  method to facilitate radioimaging with technetium-99m
(1 time)
Science
(1 time)
sFv (1 time)
1995 Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.
79  method to locate occult breast lesions using technetium-99m
(1 time)
Gynecology
(1 time)
--- 2000 Use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions.
80  method using technetium-99m
(1 time)
Radiology
(1 time)
FF (1 time)
1983 The influence of contrast medium dose on filtration fraction in the rabbit kidney.
81  method, dobutamine technetium 99m
(1 time)
Cardiology
(1 time)
CABG (1 time)
SPECT (1 time)
2003 Additive value of low-dose dobutamine to technetium-99m sestamibi-gated single-photon emission computed tomography for prediction of wall motion improvement in patients undergoing coronary artery bypass graft.
82  method, with dual plasma sampling technetium 99m
(1 time)
Radiology
(1 time)
CT (1 time)
DTPA (1 time)
GFR (1 time)
2016 Determination of Glomerular Filtration Rate with CT Measurement of Renal Clearance of Iodinated Contrast Material versus 99mTc-DTPA Dynamic Imaging "Gates" Method: A Validation Study in Asymmetrical Renal Disease.
83  methods for estimation of Technetium Tc 99m
(1 time)
Veterinary Medicine
(1 time)
131I-OIH (1 time)
2001 Simplified methods for estimation of 99mTc-pentetate and 131I-orthoiodohippurate plasma clearance in dogs and cats.
84  methods of reconstructing technetium 99m
(1 time)
Radiology
(1 time)
DMSA (1 time)
FBP (1 time)
SPECT (1 time)
2009 Pediatric 99mTc-DMSA SPECT performed by using iterative reconstruction with isotropic resolution recovery: improved image quality and reduced radiopharmaceutical activity.
85  METHODS: 88BV59, labeled with technetium Tc 99m
(1 time)
Neoplasms
(1 time)
CEA (1 time)
CT (1 time)
HAHA (1 time)
1998 Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies.
86  METHODS: D-D3 was radiolabeled with technetium-99m
(1 time)
Medicine
(1 time)
ProGRP (1 time)
SCLC (1 time)
T/B (1 time)
2020 Pretargeted radioimmunoimaging with a biotinylated D-D3 construct and 99mTc-DTPA-biotin: strategies for early diagnosis of small cell lung cancer.
87  methods: In the present experiment, technetium-99m
(1 time)
Nanomedicine
(1 time)
--- 2018 Technetium-99m chelator-free radiolabeling of specific glutamine tumor imaging nanoprobe: in vitro and in vivo evaluations.
88  METHODS: LS using technetium-99m sulfur colloid
(1 time)
General Surgery
(1 time)
BMI (1 time)
IM (1 time)
LS (1 time)
2006 Lymphoscintigraphy does not enhance sentinel node identification or alter management of patients with early breast cancer.
89  Methods: Lucinactant was radiolabeled by the addition of technetium-99m
(1 time)
Pulmonary Medicine
(1 time)
ADS (1 time)
GSD (1 time)
nCPAP (1 time)
2019 Deposition of Aerosolized Lucinactant in Nonhuman Primates.
90  METHODS: Technetium-99m
(1 time)
Nuclear Medicine
(1 time)
DOX (1 time)
2015 Technetium-99m-labeled doxorubicin as an imaging probe for murine breast tumor (4T1 cell line) identification.
91  METHODS: Two exercise tests using the Bruce protocol with technetium-99m
(1 time)
Cardiology
(1 time)
--- 1993 Effect of a standardized meal on the threshold of exercise-induced myocardial ischemia in patients with stable angina.
92  mice and were infused with RRx-001-treated and Technetium-99m
(1 time)
Chemistry
(1 time)
HUVEC (1 time)
LPS (1 time)
RBCs (1 time)
2021 RRx-001 Increases Erythrocyte Preferential Adhesion to the Tumor Vasculature.
93  mice following intravenous injection of Technetium-99m
(1 time)
Neoplasms
(1 time)
mAbs (1 time)
sdAbs (1 time)
2019 Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent.
94  mice were labelled with Technetium 99m
(1 time)
Neoplasms
(1 time)
3-MCA (1 time)
LAI (1 time)
LNC (1 time)
1974 Leukocyte adherence inhibition as measured by a radioisotopic technique for detection of cell-mediated tumor immunity.
95  mice, using Technetium-99m
(1 time)
Oncogenes
(1 time)
Nbs (1 time)
2017 Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers.
96  microemulsion formulations, determine brain drug delivery through biodistribution using technetium-99m
(1 time)
Drug Design
(1 time)
--- 2009 Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
97  microg of technetium 99m
(1 time)
Therapeutics
(1 time)
HFA-227 (1 time)
MDI (1 time)
MF (1 time)
2001 Regional lung deposition of a technetium 99m-labeled formulation of mometasone furoate administered by hydrofluoroalkane 227 metered-dose inhaler.
98  microspheres and technetium-99m
(1 time)
Nuclear Medicine
(1 time)
166Ho (1 time)
SPECT (1 time)
UMCS (1 time)
2020 Simultaneous 166Ho/99mTc dual-isotope SPECT with Monte Carlo-based downscatter correction for automatic liver dosimetry in radioembolization.
99  mild intraventricular septal thickness and technetium-99m
(1 time)
Nephrology
(1 time)
apoA-II (1 time)
Arg (1 time)
2003 Hereditary systemic amyloidosis associated with a new apolipoprotein AII stop codon mutation Stop78Arg.
100  milk-technetium 99m
(1 time)
General Surgery
(1 time)
DU (1 time)
HSV (1 time)
TV-GJ (1 time)
1994 Gallbladder emptying after antiulcer gastric surgery.